Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum
- Sponsor
- Hospital Universitario 12 de Octubre
- Study ID
- NCT07095829
- Status
- Recruiting
Conditions
- Congenital Heart Disease
- Fetal Cardiac Disorder
- Pulmonary Atresia With Intact Ventricular Septum
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Weeks - 28 Weeks
- Healthy Volunteers
- Not accepted
Interventions
- No intervention — OTHEREvaluation of natural history of the disease
Study Details
Pulmonary atresia (PA)/critical stenosis (CS) with intact ventricular septum (PA/CS-IVS) is a rare congenital heart disease (CHD), that presents heterogeneously. Prognosis is conditioned by the possibility of achieving a primary repair with biventricular circulation (BV) or a one-and-a-half ventricle solution vs. a palliative approach bound to a univentricular (UV) circulation in which both survival and quality of life are significantly impaired. Predicting UV circulation prenatally is still a challenge. The aim of this study is: 1/ to evaluate the natural history of the disease and develop a prognostic model for the prediction of transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age 2/ To develop a model to predict the risk of right ventricle dependent coronary circulation 3/ To evaluate prenatal and postnatal outcomes in non-intervened fetuses with a confirmed postnatal diagnosis of PA-CS/IVS including Intrauterine death, neonatal/Infant death, number of required postnatal procedures, need for oxygen support, need for cardiac transplantation
Key Dates
- First listed
- Jul 31, 2025
- Start date
- Feb 1, 2024
- Status verified
- Sep 2025
- Primary completion
- Feb 1, 2028
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Retrospective cohortRetrospective cases that meet all the inclusion criteria and none of the exclusion criteria from 2013 until 2023 will be included for model development. They should be non-intervened cases in order to assess the natural history of the disease.
- Arm: Prospective cohortProspectively recruited cases will be included when meeting all the inclusion criteria and none of the exclusion ones. This cohort will serve as a validation cohort for the previously developed model. The nature of the study is observational. Clinicians will not be given the result of the model during the study and clinical practice will be routine.
Primary Outcome Measure
Prediction of postnatal circulation [ Time Frame: 3 years (1 recruitment, 2 follow-up) ]
Central Contacts
- Cecilia Villalain, MD PhD+34913908310
- Alberto Galindo, MD PhD+34913908310
Related Studies
- Molecular and Cellular Characterization of Cardiac Tissue in Postnatal DevelopmentRecruiting · Emory University · Atlanta, Georgia
- Genetics of Congenital Heart DiseaseRecruiting · Nationwide Children's Hospital · Columbus, Ohio
- MRI and Computational Simulation Cardiology StudyEnrolling By Invitation · Stanford University · Palo Alto, California
- ATrial Tachycardia PAcing Therapy in Congenital HeartRecruiting · Ian Law · Los Angeles, California